Mega Cv

# Amoxicillin/Clavulanate (Mega cv) ## Overview - **Classification**: Beta-lactam antibiotic, Penicillin + Beta-lactamase inhibitor - **Mechanism**: Amoxicillin inhibits bacterial cell wall synthesis. Clavulanate inactivates bacterial beta-lactamase enzymes, preventing amoxicillin degradation. ## Primary Indications 1. **Acute Bacterial Sinusitis** - Due to beta-lactamase producing strains. 2. **Otitis Media** - Often in pediatric patients, effective against resistant strains. 3. **Lower Respiratory Tract Infections** - Including community-acquired pneumonia, acute exacerbations of chronic bronchitis. 4. **Skin and Skin Structure Infections** - Such as animal/human bite wounds, cellulitis. 5. **Urinary Tract Infections** - Caused by susceptible organisms. ## Adult Dosing ### Standard Dosing (Doses are Amoxicillin/Clavulanate) **Acute Bacterial Sinusitis, Otitis Media, Lower Respiratory Tract, Skin/Skin Structure Infections** - **Dose**: **875 mg**/ **125 mg** or **500 mg**/ **125 mg** - **Frequency**: **875 mg/125 mg** every **12 hours**; **500 mg/125 mg** every **8 hours** - **Route**: Oral - **Duration**: 7-14 days (e.g., 10-14 days for sinusitis/otitis; 7 days for skin/structure). **Urinary Tract Infections** - **Dose**: **500 mg**/ **125 mg** - **Frequency**: Every **8 hours** - **Route**: Oral - **Duration**: 3-7 days. ### Dose Adjustments - **Renal Impairment**: Based on amoxicillin component. - CrCl **>30 mL/min**: No adjustment. - CrCl **10-30 mL/min**: **250-500 mg** (amox) every **12 hours** (Max 500 mg/125 mg BID). - CrCl **<10 mL/min**: **250-500 mg** (amox) every **24 hours** (Max 500 mg/125 mg daily). - **Hemodialysis**: **250-500 mg** (amox) every **24 hours**, with an additional dose during/after dialysis. - **Hepatic Impairment**: Use with caution; monitor liver function regularly. - **Elderly Patients**: Adjust dose based on renal function and monitor for adverse effects. ## Pediatric Dosing (Doses are based on Amoxicillin component) ### Neonates (0-28 days) - **Dose**: **Not generally recommended** due to immature renal function. - **Special Notes**: If use is unavoidable, consult expert; consider **20 mg/kg/day** (amox) divided every **12 hours**. ### Infants (1-12 months) - **Dose**: **25-45 mg/kg/day** (amox) divided every **12 hours**. - Higher dose (45 mg/kg/day) for severe infections like otitis media. - **Frequency**: Every **12 hours**. - **Maximum**: **1000 mg/day** (amox component). - **Special Notes**: Use pediatric suspension (e.g., 200 mg/28.5 mg or 400 mg/57 mg per 5mL). ### Children (1-12 years) - **Dose**: **25-45 mg/kg/day** (amox) divided every **12 hours** OR **20-40 mg/kg/day** divided every **8 hours**. - **Higher dose (45 mg/kg/day)** for otitis media, sinusitis, LRTI. - **Lower dose (25 mg/kg/day)** for less severe infections like skin/UTI. - **Frequency**: Every **8 or 12 hours** depending on product and dose. - **Maximum**: Do not exceed adult doses (e.g., **875 mg**/ **125 mg** BID). - **Special Notes**: Available in various suspension strengths (e.g., 400 mg/57 mg per 5mL for BID dosing). ### Adolescents (13-18 years) - **Dose**: Typically follows **adult dosing** based on weight and severity of infection. - **Maximum**: **Adult dose** (e.g., **875 mg**/ **125 mg** BID). ## Safety Information ### Contraindications - **Absolute**: History of severe hypersensitivity to beta-lactam antibiotics (e.g., anaphylaxis). - **Absolute**: History of amoxicillin/clavulanate-associated cholestatic jaundice or hepatic dysfunction. - **Relative**: Infectious mononucleosis (increased risk of rash). ### Common Adverse Effects - **Very Common (>10%)**: Diarrhea, Nausea, Vomiting. - **Common (1-10%)**: Rash, Urticaria, Headache, Vaginitis. - **Serious but Rare**: Clostridioides difficile-associated diarrhea (CDAD), Cholestatic jaundice, Hepatic dysfunction, Anaphylaxis, Stevens-Johnson Syndrome (SJS). ### Key Drug Interactions - **Warfarin**: Increased INR, risk of bleeding. Monitor INR closely, adjust warfarin dose. - **Methotrexate**: Increased methotrexate levels, increased toxicity. Avoid co-administration or monitor closely. - **Probenecid**: Increases and prolongs amoxicillin blood levels. Avoid concurrent use if possible. - **Oral Contraceptives**: May decrease efficacy. Advise using backup contraception. ## Monitoring & Follow-up - **Before Treatment**: Obtain culture & susceptibility if appropriate. Assess renal/hepatic function in impaired patients. - **During Treatment**: Monitor for therapeutic response (resolution of symptoms). Monitor for signs of adverse reactions (e.g., severe diarrhea, rash, jaundice). - **Clinical Signs**: Watch for worsening infection, severe watery diarrhea (CDAD), yellowing of skin/eyes (jaundice), dark urine, or unusual bruising/bleeding. ## Clinical Pearls - 💡 **Tip 1**: Administer at the start of a meal to reduce GI upset and enhance absorption. - 💡 **Tip 2**: Suspensions must be shaken well before each use and refrigerated. Discard any unused portion after 10 days. - 💡 **Tip 3**: Counsel patients to complete the entire prescribed course, even if symptoms improve, to prevent resistance. - 💡 **Tip 4**: Be aware of the varying amoxicillin-to-clavulanate ratios; ensure appropriate strength is prescribed (e.g., ES-600 for specific pediatric infections). > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.